Your browser doesn't support javascript.
Pulmonary Embolism Response Team utilization during the COVID-19 pandemic.
Finn, Matthew T; Gogia, Shawn; Ingrassia, Joseph J; Cohen, Matthew; Madhavan, Mahesh V; Nabavi Nouri, Shayan; Brailovsky, Yevgeniy; Masoumi, Amir; Fried, Justin A; Uriel, Nir; Agerstrand, Cara I; Eisenberger, Andrew; Einstein, Andrew J; Brodie, Daniel; B Rosenzweig, Erika; Leon, Martin B; Takeda, Koji; Pucillo, Anthony; Green, Philip; Kirtane, Ajay J; Parikh, Sahil A; Sethi, Sanjum S.
  • Finn MT; Department of Cardiology, Columbia Irving Medical Center, New York, NY, USA.
  • Gogia S; Cardiovascular Research Foundation, New York, NY, USA.
  • Ingrassia JJ; Department of Cardiology, Columbia Irving Medical Center, New York, NY, USA.
  • Cohen M; Inteventional Cardiology, Hartford Hospital, Hartford, CT, USA.
  • Madhavan MV; Department of Cardiology, Columbia Irving Medical Center, New York, NY, USA.
  • Nabavi Nouri S; Department of Cardiology, Columbia Irving Medical Center, New York, NY, USA.
  • Brailovsky Y; Cardiovascular Research Foundation, New York, NY, USA.
  • Masoumi A; Department of Cardiology, Columbia Irving Medical Center, New York, NY, USA.
  • Fried JA; Department of Cardiology, Columbia Irving Medical Center, New York, NY, USA.
  • Uriel N; Department of Cardiology, Columbia Irving Medical Center, New York, NY, USA.
  • Agerstrand CI; Department of Cardiology, Columbia Irving Medical Center, New York, NY, USA.
  • Eisenberger A; Department of Cardiology, Columbia Irving Medical Center, New York, NY, USA.
  • Einstein AJ; Cardiovascular Research Foundation, New York, NY, USA.
  • Brodie D; Department of Pulmonology, Columbia Irving Medical Center, New York, NY, USA.
  • B Rosenzweig E; Department of Hematology/Oncology, Columbia Irving Medical Center, New York, NY, USA.
  • Leon MB; Department of Cardiology, Columbia Irving Medical Center, New York, NY, USA.
  • Takeda K; Department of Pulmonology, Columbia Irving Medical Center, New York, NY, USA.
  • Pucillo A; Department of Cardiology, Columbia Irving Medical Center, New York, NY, USA.
  • Green P; Department of Pediatric Cardiology, Columbia Irving Medical Center, New York, NY, USA.
  • Kirtane AJ; Department of Cardiology, Columbia Irving Medical Center, New York, NY, USA.
  • Parikh SA; Cardiovascular Research Foundation, New York, NY, USA.
  • Sethi SS; Department of Cardiothoracic Surgery, Columbia Irving Medical Center, New York, NY, USA.
Vasc Med ; 26(4): 426-433, 2021 08.
Article in English | MEDLINE | ID: covidwho-1166685
ABSTRACT
Coronavirus disease 2019 (COVID-19) may predispose patients to venous thromboembolism (VTE). Limited data are available on the utilization of the Pulmonary Embolism Response Team (PERT) in the setting of the COVID-19 global pandemic. We performed a single-center study to evaluate treatment, mortality, and bleeding outcomes in patients who received PERT consultations in March and April 2020, compared to historical controls from the same period in 2019. Clinical data were abstracted from the electronic medical record. The primary study endpoints were inpatient mortality and GUSTO moderate-to-severe bleeding. The frequency of PERT utilization was nearly threefold higher during March and April 2020 (n = 74) compared to the same period in 2019 (n = 26). During the COVID-19 pandemic, there was significantly less PERT-guided invasive treatment (5.5% vs 23.1%, p = 0.02) with a numerical but not statistically significant trend toward an increase in the use of systemic fibrinolytic therapy (13.5% vs 3.9%, p = 0.3). There were nonsignificant trends toward higher in-hospital mortality or moderate-to-severe bleeding in patients receiving PERT consultations during the COVID-19 period compared to historical controls (mortality 14.9% vs 3.9%, p = 0.18 and moderate-to-severe bleeding 35.1% vs 19.2%, p = 0.13). In conclusion, PERT utilization was nearly threefold higher during the COVID-19 pandemic than during the historical control period. Among patients evaluated by PERT, in-hospital mortality or moderate-to-severe bleeding were not significantly different, despite being numerically higher, while invasive therapy was utilized less frequently during the COVID-19 pandemic.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Patient Care Team / Pulmonary Embolism / Practice Patterns, Physicians' / Thrombolytic Therapy / Venous Thromboembolism / COVID-19 / Health Resources / Health Services Needs and Demand Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Vasc Med Journal subject: Vascular Diseases Year: 2021 Document Type: Article Affiliation country: 1358863X21995896

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Patient Care Team / Pulmonary Embolism / Practice Patterns, Physicians' / Thrombolytic Therapy / Venous Thromboembolism / COVID-19 / Health Resources / Health Services Needs and Demand Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Vasc Med Journal subject: Vascular Diseases Year: 2021 Document Type: Article Affiliation country: 1358863X21995896